Joel S. Marcus - 23 Jun 2023 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
23 Jun 2023
Transactions value $
$0
Form type
4
Filing time
27 Jun 2023, 17:11:16
Previous filing
08 Jun 2023
Next filing
19 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Award $0 +1.57K $0.00 1.57K 23 Jun 2023 Common Stock 1.57K Direct F1, F2
transaction ITCI Stock Option (right to buy) Award $0 +7.01K $0.00 7.01K 23 Jun 2023 Common Stock 7.01K $63.79 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On June 23, 2023, the reporting person was granted 1,567 restricted stock units, vesting on the first anniversary of the grant date (June 23, 2024).